HOXA9 and acute myeloid leukemia: In addition, using a CRISPR/cas9 negative selection screen, Kühn and Armstrong confirmed that the binding of wild-type MLL to menin was critical for the expression of HOXA9, MEIS1, and FLT3 in NPM1-mutated AML cells [104].